Novartis exec joining BIAL as chief commercial officer

Portugal’s largest drugmaker BIAL is boosting its management team with the addition of a former big pharma exec, Max Bricchi, as its chief commercial officer he will also join the executive board.

With responsibility for the entire global commercial operations, Mr Bricchi’s focus will be to consolidate the company's internationalization strategy, based on the growth of BIAL's current and future portfolio, namely its innovative medicines, bringing BIAL solutions to people living with severe diseases across the world.

Mr Bricchi joins BIAL from Switzerland’s Novartis (NOVN: VX), where, since 2020, he served as the global head the firm’s neuroscience franchise.